Learning

November 23, 2018

Valproic acid-based learning/memory/cognitive-enhancement therapy: Valproic acid (brand name: Convulex, Stavzor, and others), used in the treatment of epilepsy, bipolar disorder and migraine, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/November/2018, 7.07 am

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center […]
November 22, 2018

Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes, 22/November/2018, 10.56 pm

Introduction: What they say A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center […]
November 14, 2018

Mechanistic insights into how ADNP enhances learning, memory and cognition: ADNP (Activity-dependent neuroprotective protein) increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 14/November/2018, 3.20 pm

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center […]
November 12, 2018

Mechanistic insights into how Aliskiren functions as a learning/memory/cognitive-enhancer: Aliskiren (brand name: Tekturna and Rasilez) ), a renin inhibitor used in the treatment of essential hypertension, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 12/November/2018, 9.42 pm

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center […]